PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Sep-2022 Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Relief Therapeutics Holding SA
06-Sep-2022 Zymeworks Announces Release Of ESMO Abstract For Phase 1 Study Of Zanidatamab Zovodotin (ZW49) In Solid Cancers Zymeworks
06-Sep-2022 The 2022 International Pharma Logistics Masterclass brings to Abu Dhabi 120 industry experts, academics, and policymakers from 21 countries Pharma.Aero
06-Sep-2022 New analyses in real-world setting support the effectiveness of Fasenra in severe eosinophilic asthma AstraZeneca
06-Sep-2022 Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU Pleco Therapeutics
06-Sep-2022 Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology ABIVAX
06-Sep-2022 Formycon publishes preliminary figures for the first half of 2022 Formycon AG
06-Sep-2022 Spexis provides business update and announces financial results for the first half of 2022 Spexis AG
06-Sep-2022 Lonza and Touchlight collaborate on end-to-end mRNA offering Lonza Group AG
06-Sep-2022 Biotest AG: Biotest AG opens 12th plasma collection centre in the Czech Republic Biotest AG
05-Sep-2022 aap launches partnership with strategic investor from the Asian region and resolves on capital increase of around 10 % aap Implantate AG
02-Sep-2022 Abivax publishes a prospectus in the context of its capital increase ABIVAX
02-Sep-2022 Sosei Heptares Wins Licensing Deal of the Year and Executive of the Year at the Inaugural Informa Pharma Intelligence Awards Japan Sosei Heptares
02-Sep-2022 ISPE Announces the 2022–2023 ISPE International Board of Directors Election Results The International Society of Pharmaceutical Engineering (ISPE)
02-Sep-2022 Almirall: Lebrikizumab’s 52-week late-breaking data will be presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress Almirall
02-Sep-2022 Macomics to Present at Upcoming Conferences, Q3 2022 Macomics Ltd
02-Sep-2022 Amolyt Pharma Announces Two Presentations, Including Phase 2a Data for AZP-3601 in Patients with Hypoparathyroidism, at the American Society for Bone and Mineral Research 2022 Annual Meeting Amolyt Pharma
02-Sep-2022 Aptar Pharma Expands Human Factors Capabilities Through Acquisition of Metaphase Design Group, Inc. Aptar Pharma
02-Sep-2022 ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financing with top-tier US and European Biotech investors ABIVAX
01-Sep-2022 Hempamed Rx: SynBiotic SE launches full-line medical cannabis brand SynBiotic SE